A new report from specialist pharma and biotech consultancy Novasecta explores how the world’s top 100 pharma companies are shaping the future of healthcare. Novasecta’s Global 100 is based on total group revenues (2018) of all organisations that have pharmaceutical interests, with the aim of benchmarking industry performance in its fullest context.
Continue at: https://pharmaboardroom.com/facts/the-novasecta-global-100/
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link